Partial restoration of counterregulatory circulating glucagon by dapagliflozin and low-dose glibenclamide in men with type 1 diabetes: in vitro studies and randomised clinical crossover trial.

EBioMedicine · 2026 · PMC13213787 · PMID 42155411

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although a trend towards reduced occurrence of hypoglycaemia with 0.3 mg/day glibenclamide was observed, this effect did not reach statistical significance ( Fig. 8 , inset).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.